From payer friction to behavioral drop-off, GLP-1s are challenging pharma to rethink how success is measured in the obesity and diabetes markets
Those are different bets, and only direct comparative trials can settle which performs better in the same patient population
Kruk B, Milkiewicz M, Raszeja-Wyszomirska J, Milkiewicz P, Krawczyk M
Ingredients Bulking agent cellulose, L-glutathione reduced, carriers calcium phosphate and cross-linked sodium carboxymethyl cellulose, lactose monohydrate, pomegranate peel extract (Punica L.), superoxide dismutase, maltodextrin, milk thistle seed extract (Silybum marianum L.), L-cysteine, anti-caking agents magnesium salts of fatty acids and silicon dioxide, glazing agent (neutral methacrylate copolymer, talc, propylene glycol, colorant carmine)
The low pH (approx
Potential Role in Managing Chronic Illnesses Research suggests that glutathione may play a supportive role in managing conditions like diabetes, Parkinsons disease and autoimmune disorders due to its antioxidant and detoxifying properties